Coronary heart disease, what are the items reviewed

Patients with coronary heart disease need to adhere to standard treatment for a long time, and they must also be reviewed regularly to understand the treatment, rehabilitation effects, and the safety of treatment measures. Usually, patients need to review the following items:

Patients with blood routine coronary heart disease need to take β-blockers, nitrate drugs, lipid-lowering drugs, antiplatelet drugs, etc. for a long time, these drugs may affect white blood cells, platelets and hemoglobin in the human body, so coronary heart disease The patient should review the blood routine.

Urine routine coronary heart disease patients often suffer from high blood pressure, diabetes and other diseases, these diseases can cause kidney damage, resulting in proteinuria and so on. Therefore, patients with coronary heart disease need to test urine routines to understand whether they have kidney damage.

Patients with fetal occult blood coronary heart disease need to take aspirin for a long time, and patients who implant stents also need to use clopidogrel in combination. Both drugs are prone to cause gastrointestinal bleeding. Therefore, patients with coronary heart disease, especially those who originally had gastrointestinal diseases such as ulcer disease, and patients with a history of drinking alcohol, in addition to paying attention to gastrointestinal symptoms and observing the presence or absence of black stools, it is best to regularly check the stool occult blood.

The electrocardiogram regularly rechecks the electrocardiogram to find out whether there is new myocardial ischemia and arrhythmia. Especially when patients with coronary heart disease have symptoms, they should be reviewed in time.

Many drugs used by patients with coronary heart disease may cause liver and kidney damage, so liver and kidney function needs to be tested. Statin lipid-lowering drugs are drugs that must be taken by patients with coronary heart disease. Their side effects are increased transaminases and may cause rhabdomyolysis. Especially during the initial administration, patients should test liver function to understand the levels of transaminase and creatine creatine, and use it as a reference for future review.

Hyperglycemia, hyperglycemia, and hyperlipidemia are important risk factors for coronary heart disease. Clinical treatment of coronary heart disease requires the control of blood glucose and blood lipids to meet the standard. This requires regular review of blood glucose and blood lipids. In view of the large fluctuation of random blood glucose and many influencing factors, glycated hemoglobin can be checked.

Echocardiography patients with coronary heart disease regularly review the echocardiogram to understand the size, shape, wall thickness and movement of each chamber of the heart, valve structure and function, etc. It is used to evaluate the overall structure and function of the heart of the patient and whether there is recurrence Myocardial ischemia is of great significance.

Exercise stress electrocardiogram test This test is an effective method to evaluate whether myocardial ischemia relapses or activity tolerance, and has a positive significance for evaluating cardiac function.

Radionuclide myocardial perfusion imaging is a valuable tool for the diagnosis of coronary heart disease, the evaluation of the extent and scope of coronary artery disease, the estimation of viable myocardium, the evaluation of cardiac function, the evaluation of therapeutic effect and prognosis. Non-invasive method of inspection.

Coronary artery CT Coronary artery CT is a good method for noninvasive detection of coronary artery stenosis. However, errors are likely to occur when calcified lesions and tortuous blood vessels occur, and the stent also has a certain effect on imaging, so the effect of this review on restenosis within the stent is limited.

Coronary angiography is to determine the coronary artery lesions that cause ischemia. Patients with recurrent myocardial ischemia should undergo coronary angiography. Coronary angiography can clearly show the anatomy of the patient’s coronary arteries, make accurate judgments on the original lesions and new lesions, and can also make accurate judgments on whether there is restenosis in the stent. However, if the patient’s comprehensive condition does not allow or is not prepared for revascularization (bypass surgery or interventional therapy), coronary angiography is not necessary.